ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2026
Patterns of prescription stimulant initiation before and during the COVID-19 pandemic: a population-based time-series analysis.
Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSome jurisdictions reported increased stimulant prescribing during the COVID-19 pandemic. We sought to examine patterns of stimulants dispensed to adults in Ontario and characterize adults who initiated such therapy before and during the pandemic.
methodsWe used population health administrative data to identify monthly rates of incident stimulant dispensations to adults in Ontario, Canada, between January 2016 and June 2024. We conducted an interrupted time-series analysis using piecewise regression to assess the immediate and sustained impact of the COVID-19 pandemic on stimulant dispensing rates.
resultsAmong 327 053 adults who initiated stimulants, the median age was 31 years and 55.4% were female. Compared with before the COVID-19 pandemic, new recipients during the pandemic were more likely to be aged 25 to 34 years (26.5% v. 32.8%) and female (48.0% v. 59.0%), while stimulants were less likely to be initiated by psychiatrists (25.5% v. 18.0%). The rate of new stimulant dispensations was stable before the COVID-19 pandemic (change in monthly rate per 1000 people 0.0004, 95% confidence interval [CI] -0.0001 to 0.0009), declined immediately at the start of the pandemic (-0.067, 95% CI -0.092 to -0.043), and accelerated thereafter (0.0029, 95% CI 0.0018 to 0.004), rising from 0.16 to 0.44 new monthly dispensations per 1000 people between January 2016 and June 2024. Results were consistent when stratified by age, trends and were generally higher during the pandemic among females than males.
interpretationIn Ontario, rates of new prescriptions for stimulants dispensed to adults accelerated rapidly during the COVID-19 pandemic. Monitoring and evaluation are needed to ensure appropriateness of use and safeguard against potential harms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.